Home › Myelofibrosis › Washington › Seattle

Pag-aaral pangklinika para sa Myelofibrosis sa Seattle, WA

Isang pag-aaral para sa Myelofibrosis ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

Nagre-recruitPhase 3

Fred Hutch Cancer Research, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07357727

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Nagre-recruitPhase 3

University of Washington, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07623161

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

Nagre-recruitPhase 2

GSK Investigational Site, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06517875

A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms

Nagre-recruitPhase 1

Site US22, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07849231

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Nagre-recruitPhase 1/2

University of Washington, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT05320198

Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes

Nagre-recruitPhase 2

Fred Hutch/University of Washington Cancer Consortium, Seattle

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07228624

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Nagre-recruitPhase 1/2

University of Washington - Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04176198

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Nagre-recruitPhase 2

Fred Hutch/University of Washington Cancer Consortium, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04282187

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Nagre-recruitPhase 2

Fred Hutch/University of Washington Cancer Consortium, Seattle

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT04370301

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 2

Fred Hutchinson Cancer Center, Seattle

Edad 18 hanggang 66 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06859424

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Seattle

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Nagre-recruitPhase 3

Fred Hutchinson Cancer Centre, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2025 · NCT06479135

Pag-aaral para sa Myelofibrosis sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.